Study points to novel treatment for mitochondrial disease
Research
Stanford Medicine research shows healthy cells from bone marrow transplants can transfer mitochondria to unhealthy neighbors, offering a possible treatment for a group of rare genetic diseases.
What teens say about the harms they face online
Analysis & Insights
A Stanford-led survey offers one of the first comprehensive looks at teens’ experiences with harassment, harmful content, and sleep disruption.
Warning labels could curb young people’s social media use
Research
Teens and young adults report that health warning labels would reduce their social media consumption. Messages about mental health harms resonate most strongly.
What bemotrizinol could mean for U.S. sun protection
Analysis & Insights
The FDA finally gave the green light to bemotrizinol. Stanford Medicine experts share why it’s considered a massive leap forward for skin health in the U.S.
Trial shows food-allergy treatments let kids eat safely
News
Children with multiple food allergies have several treatment options – including omalizumab and oral immunotherapy – a Stanford Medicine trial has found.
Research projects advance family-first approach to infant care
Research
Stanford-led teams in U.S. NICUs and rural India are working to make parents active partners in newborn care, an approach linked to better outcomes for vulnerable infants.
Study finds two effective ARFID treatments for kids
Research
Family- and individual-based therapy both improve eating variety in children with the pediatric eating disorder ARFID.
What the new U.S. dietary guidelines mean for kids
News
Stanford Medicine pediatrician Anisha Patel shares five things to know about the new federal guidelines on nutrition.
Individual brain scans reveal behavior control differences
News
Analyzing individual brain scans rather than averages uncovers important differences in how children manage behavior, particularly in goal-oriented tasks, new research shows.
Stanford Medicine opens novel proton therapy center
Video
The center is the first in the world to introduce ultracompact proton therapy, making advanced targeted radiotherapy more accessible to pediatric and adult patients.